---
figid: PMC5708962__medi-96-e8725-g005
figtitle: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC5708962
filename: medi-96-e8725-g005.jpg
figlink: /pmc/articles/PMC5708962/figure/F5/
number: F5
caption: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA. TKI = tyrosine
  kinase inhibitor, VEGFA = vascular endothelial growth factor A, VEGFR2 = vascular
  endothelial growth factor receptor 2.
papertitle: Apatinib concurrent gemcitabine for controlling malignant ascites in advanced
  pancreatic cancer patient.
reftext: Lijun Liang, et al. Medicine (Baltimore). 2017 Nov;96(47):e8725.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5735924
figid_alias: PMC5708962__F5
figtype: Figure
redirect_from: /figures/PMC5708962__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5708962__medi-96-e8725-g005.html
  '@type': Dataset
  description: Mechanism of action of VEGFA/VEGFR2 pathway on the formation of MA.
    TKI = tyrosine kinase inhibitor, VEGFA = vascular endothelial growth factor A,
    VEGFR2 = vascular endothelial growth factor receptor 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - mid
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
---
